Tenon Medical, Inc. cash flow to debt ratio of -7.62K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Tenon Medical, Inc.'s free cash flow has decreased 9.48% from $-10.06M last year to $-11.02M, signaling decreasing performance

Tenon Medical, Inc.'s debt to equity ratio is 2.57, which means that the company's assets are unhealthy financed, signaling financial risk.

Tenon Medical, Inc.'s debt has increased relative to shareholder equity from 0.07 last year to 2.57 today, signaling weakened financials

Tenon Medical, Inc. has a net cash position, so leverage is healthy.

Tenon Medical, Inc.'s interest coverage ratio of 70.62 indicates that earnings with good margin can cover interest payments on company debt

Tenon Medical, Inc.'s profit margin has increased (-35.70%) in the last year from -417.24% to -268.28%, signaling increasing performance

Tenon Medical, Inc.'s short-term assets of $6.77M exceed its short-term liabilities of $3.21M

Tenon Medical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Tenon Medical, Inc.'s return on equity of -268.55%, is lower than 15.00%, indicating bad performance

Tenon Medical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Tenon Medical, Inc. has insufficient public price history to evaluate earnings stability.

Tenon Medical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Tenon Medical, Inc. has negative free cash flow, indicating cash burn

Tenon Medical, Inc.'s yearly earnings has increased -8.17% since last year from $-13.67M to $-12.56M, signaling increasing performance

Tenon Medical, Inc.'s yearly revenue has increased 20.35% since last year from $3.28M to $3.94M, signaling increasing performance

ROIC -136.22% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Tenon Medical, Inc.'s 3-year revenue CAGR of 78.71% is positive, indicating growing revenue over the past 3 years

Tenon Medical, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Tenon Medical, Inc. has insufficient public price history to evaluate ROE consistency.

Tenon Medical, Inc. has insufficient data to evaluate this check.

Tenon Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Tenon Medical, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Tenon Medical, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Tenon Medical, Inc. has insufficient data to evaluate this check.

Tenon Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Tenon Medical, Inc. has a price-to-book ratio of 1.03x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Tenon Medical, Inc. has a price-to-sales ratio of 0.42x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue